Eurazeo SE
XBER:EUQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eurazeo SE
XBER:EUQ
|
FR |
|
E
|
Encore Capital Group Inc
XBER:ECP
|
US |
|
Rapt Therapeutics Inc
NASDAQ:RAPT
|
US |
|
H
|
Hugo Boss AG
F:BOSA
|
DE |
|
V
|
Verrica Pharmaceuticals Inc
F:1NE
|
US |
|
Greenlam Industries Ltd
NSE:GREENLAM
|
IN |
|
H
|
Heineken Malaysia Bhd
KLSE:HEIM
|
MY |
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
Technocraft Industries (India) Ltd
BSE:532804
|
IN |
|
O
|
OHB SE
DUS:OHB
|
DE |
Wall St Price Targets
EUQ Price Targets Summary
Eurazeo SE
According to Wall Street analysts, the average 1-year price target for EUQ is 63.79 EUR with a low forecast of 51.33 EUR and a high forecast of 75.6 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EUQ's stock price target?
Price Target
63.79
EUR
According to Wall Street analysts, the average 1-year price target for EUQ is 63.79 EUR with a low forecast of 51.33 EUR and a high forecast of 75.6 EUR.
What is the Revenue forecast for Eurazeo SE?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been -15%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Eurazeo SE?
Projected CAGR
150%
Over the last 14 years, the compound annual growth rate for Operating Income has been -11%. The projected CAGR for the next 2 years is 150%.
